| scholarly article | Q13442814 |
| P50 | author | Merry L. Lindsey | Q47610305 |
| P2093 | author name string | Jun Yan | |
| Guo-Chang Fan | |||
| Qingqing Wang | |||
| Yonggang Ma | |||
| Xiaowei Zhang | |||
| Huimin Yan | |||
| Zhuowei Hu | |||
| Ziyan Wang | |||
| Wenfeng Cai | |||
| Su Mi | |||
| Huayan Bao | |||
| P2860 | cites work | Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices. | Q51715131 |
| Bacillus Calmette-Guérin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment. | Q54422173 | ||
| Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury | Q57374682 | ||
| Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein | Q79294293 | ||
| Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart | Q80392200 | ||
| Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment | Q83089214 | ||
| Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms | Q84762346 | ||
| High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal | Q28242907 | ||
| High mobility group box 1 protein interacts with multiple Toll-like receptors | Q28280114 | ||
| Toll-like receptor 4 is a sensor for autophagy associated with innate immunity | Q28513852 | ||
| Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis | Q29614481 | ||
| Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large | Q33342232 | ||
| Blocking TLR2 activity attenuates pulmonary metastases of tumor | Q33490618 | ||
| Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway | Q33718319 | ||
| Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways | Q34220376 | ||
| Cardiomyopathy: an overview | Q34394878 | ||
| Cardiac inflammation and innate immunity in septic shock: is there a role for toll-like receptors? | Q34595879 | ||
| A burning issue: do sepsis and systemic inflammatory response syndrome (SIRS) directly contribute to cardiac dysfunction? | Q36250889 | ||
| Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia | Q36455977 | ||
| Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice | Q36610126 | ||
| Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management | Q36747677 | ||
| Mechanisms of disease: a 'DAMP' view of inflammatory arthritis | Q36864025 | ||
| The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity | Q36990584 | ||
| Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling | Q37263689 | ||
| Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy | Q37747554 | ||
| Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. | Q37828258 | ||
| Role of toll-like receptors in cardiovascular diseases | Q37854080 | ||
| Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27. | Q40079920 | ||
| Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response | Q40217414 | ||
| Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes | Q42496147 | ||
| TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury. | Q42497019 | ||
| Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity | Q42585599 | ||
| Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1 | Q44635445 | ||
| Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure | Q44801336 | ||
| Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice | Q45124631 | ||
| Effects of AT1- and beta-adrenergic receptor antagonists on TGF-beta1-induced fibrosis in transgenic mice. | Q45971225 | ||
| Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon | Q46371040 | ||
| Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice | Q46717362 | ||
| Transcriptional analysis of doxorubicin-induced cardiotoxicity | Q46769518 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| toll-like receptor | Q408004 | ||
| doxorubicin induced cardiomyopathy | Q55790164 | ||
| P304 | page(s) | e40763 | |
| P577 | publication date | 2012-07-13 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice | |
| P478 | volume | 7 |
| Q37679639 | Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation. |
| Q37706081 | Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes. |
| Q36237998 | Antagonism of toll-like receptor 2 attenuates the formation and progression of abdominal aortic aneurysm. |
| Q51760757 | Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective. |
| Q37729330 | Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice |
| Q35995059 | Cardiac regenerative potential of cardiosphere-derived cells from adult dog hearts |
| Q33573823 | Cardiomyocyte autophagy and cancer chemotherapy |
| Q90380221 | Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat |
| Q41125959 | Comparision of doxorubicin-induced cardiotoxicity in the ICR mice of different sources |
| Q62476511 | Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology |
| Q36709778 | Dynamic monitoring of oxidative DNA double-strand break and repair in cardiomyocytes |
| Q36457257 | Extracellular matrix and fibroblast communication following myocardial infarction |
| Q54562352 | Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation. |
| Q38423864 | Intracellular signaling of cardiac fibroblasts |
| Q36136892 | Knockout of Toll-Like Receptors 2 and 4 Prevents Renal Ischemia-Reperfusion-Induced Cardiac Hypertrophy in Mice. |
| Q41503928 | Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload |
| Q36684243 | Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation |
| Q35774310 | Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears |
| Q54977085 | Metformin Mitigates Fibrosis and Glucose Intolerance Induced by Doxorubicin in Subcutaneous Adipose Tissue. |
| Q47194979 | Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humans |
| Q38111517 | Neutrophil roles in left ventricular remodeling following myocardial infarction. |
| Q35920346 | Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats |
| Q90431745 | Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin-Induced Heart Failure Through Resolution of Toll-Like Receptor 2-Mediated Myocardial Inflammation |
| Q58592667 | The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4) |
| Q52632607 | The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure. |
| Q26753079 | The Toll of Vascular Insufficiency: Implications for the Management of Peripheral Arterial Disease |
| Q99592164 | The expression of TLR2 and TLR4 in the kidneys and heart of mice infected with Acanthamoeba spp |
| Q47553695 | The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC. |
| Q89180774 | Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice |
| Q51041012 | Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart. |
| Q51073255 | Toll-like receptor 4 knockout protects against isoproterenol-induced cardiac fibrosis: the role of autophagy. |
| Q54110673 | Toll‑Like receptor 4 promotes the phosphorylation of CRMP2 via the activation of Rho‑kinase in MCAO rats. |
Search more.